|
Jun 18
|
Roche gains 501(k) clearance for digital pathology solution for diagnostic use
|
|
Jun 18
|
Roche partners with RNA editing biotech Ascidian
|
|
Jun 18
|
Roche receives FDA clearance on its digital pathology solution for diagnostic use
|
|
Jun 17
|
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
|
|
Apr 12
|
Roche scores FDA breakthrough status for Alzheimer’s blood test
|
|
Apr 12
|
Roche, Adaptimmune part ways on cell therapy research
|
|
Apr 11
|
Why Roche Holdings Stock Popped Today
|
|
Apr 11
|
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
|
|
Apr 11
|
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
|
|
Apr 10
|
Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study
|
|
Apr 10
|
Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Feb 15
|
Cancer test firm Freenome raises $254 mln in fresh funding
|
|
Feb 13
|
Roche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics
|
|
Feb 13
|
10 Dermatologists Driving Growth for Skin Care Brands on TikTok
|
|
Feb 9
|
Roche cutting jobs in product development - media
|
|
Jan 12
|
The Zacks Analyst Blog Highlights Roche, Netflix, NIKE, Uber, Technologies and Prologis
|
|
Jan 12
|
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
|
|
Jan 11
|
Top Research Reports for Roche, Netflix & NIKE
|
|
Jan 11
|
Renewables grew rapidly in 2023, but must grow faster still to meet climate change target, IEA says
|